HCA Healthcare (HCA) PT Raised to $114.00 at Argus

HCA Healthcare (NYSE:HCA) had its price target boosted by stock analysts at Argus from $9.26 to $114.00 in a note issued to investors on Monday, The Fly reports. The brokerage presently has a “buy” rating on the stock. Argus’ target price points to a potential upside of 16.00% from the company’s previous close.

A number of other research firms also recently issued reports on HCA. Cantor Fitzgerald reaffirmed a “buy” rating and set a $115.00 price target on shares of HCA Healthcare in a research note on Tuesday, January 30th. Morgan Stanley upped their price target on shares of HCA Healthcare from $84.00 to $91.00 and gave the company an “underweight” rating in a research note on Thursday, February 1st. BMO Capital Markets upped their price target on shares of HCA Healthcare from $96.00 to $115.00 and gave the company an “outperform” rating in a research note on Thursday, February 1st. They noted that the move was a valuation call. Sanford C. Bernstein reaffirmed a “market perform” rating and set a $116.00 price target (up previously from $105.00) on shares of HCA Healthcare in a research note on Thursday, February 1st. Finally, Leerink Swann upped their price target on shares of HCA Healthcare from $105.00 to $120.00 and gave the company an “outperform” rating in a research note on Wednesday, January 31st. Three investment analysts have rated the stock with a sell rating, six have issued a hold rating and eighteen have assigned a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $104.50.

HCA Healthcare (NYSE HCA) traded up $0.44 during trading on Monday, reaching $98.28. 1,511,490 shares of the company were exchanged, compared to its average volume of 2,450,000. The stock has a market capitalization of $35,500.00, a P/E ratio of 16.55, a price-to-earnings-growth ratio of 0.98 and a beta of 0.48. The company has a current ratio of 1.62, a quick ratio of 1.36 and a debt-to-equity ratio of -6.58. HCA Healthcare has a 52 week low of $71.18 and a 52 week high of $106.84.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Tuesday, January 30th. The company reported $2.12 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.87 by $0.25. The company had revenue of $11.56 billion for the quarter, compared to the consensus estimate of $11.19 billion. HCA Healthcare had a net margin of 4.89% and a negative return on equity of 49.49%. HCA Healthcare’s revenue was up 8.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.80 earnings per share. sell-side analysts anticipate that HCA Healthcare will post 8.71 EPS for the current year.

In related news, SVP Victor L. Campbell sold 8,000 shares of the firm’s stock in a transaction dated Thursday, November 16th. The shares were sold at an average price of $75.82, for a total value of $606,560.00. Following the transaction, the senior vice president now owns 127,275 shares of the company’s stock, valued at approximately $9,649,990.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, insider Michael S. Cuffe sold 8,335 shares of the firm’s stock in a transaction dated Friday, February 9th. The stock was sold at an average price of $97.26, for a total transaction of $810,662.10. Following the completion of the transaction, the insider now directly owns 26,089 shares in the company, valued at approximately $2,537,416.14. The disclosure for this sale can be found here. Insiders sold a total of 284,469 shares of company stock worth $28,208,384 in the last ninety days. 2.90% of the stock is currently owned by insiders.

Hedge funds have recently bought and sold shares of the stock. Atlantic Trust LLC purchased a new position in HCA Healthcare in the 2nd quarter worth about $118,000. Bronfman E.L. Rothschild L.P. increased its stake in HCA Healthcare by 108.0% in the 4th quarter. Bronfman E.L. Rothschild L.P. now owns 2,425 shares of the company’s stock worth $213,000 after buying an additional 1,259 shares during the period. Kovack Advisors Inc. purchased a new position in HCA Healthcare in the 4th quarter worth about $234,000. Financial Counselors Inc. purchased a new position in HCA Healthcare in the 4th quarter worth about $243,000. Finally, Buckley Wealth Management LLC bought a new position in HCA Healthcare during the 4th quarter worth about $264,000. 75.49% of the stock is currently owned by institutional investors.

COPYRIGHT VIOLATION WARNING: This report was reported by American Banking News and is the sole property of of American Banking News. If you are reading this report on another website, it was illegally copied and reposted in violation of US & international trademark and copyright laws. The original version of this report can be accessed at https://www.americanbankingnews.com/2018/02/12/hca-healthcare-hca-pt-raised-to-114-00-at-argus.html.

HCA Healthcare Company Profile

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

The Fly

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply